Soc. Generale Knock-Out GS/ DE000SD07842 /
2024-06-06 2:05:37 PM | Chg.-0.140 | Bid2:45:05 PM | Ask2:45:05 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
19.970EUR | -0.70% | 19.900 Bid Size: 1,000 |
20.100 Ask Size: 1,000 |
Goldman Sachs Group ... | 243.9476 USD | 2078-12-31 | Call |
GlobeNewswire
2:00 PM
Fulcrum Therapeutics to Participate in the Goldman Sachs’ 45th Annual Global Healthcare Conference
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference
GlobeNewswire
1:00 PM
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:53 AM
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
GlobeNewswire
06-05
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
GlobeNewswire
05-09
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04-11
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties
GlobeNewswire
02-23
New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Busines...
GlobeNewswire
2023-10-26
New to The Street's Leadership Series Airs Two Interviews, Sam Reese, CEO, Vistage Worldwide, Inc., ...